Governance

We are grateful to our Board, Foundation and Committees for their commitment to steering the Institute to continued success.


Dr Robert (Bob) Edgar
BEcon (Hons), PhD, FAICD
Chair

Dr Edgar has extensive experience in financial services, including 25 years at ANZ Bank where he retired as Deputy Chief Executive Officer in 2009. He is also a Director on the Boards of Asciano Group, Djerriwarrh Securities, Linfox Armaguard Pty Ltd and Transurban Ltd.

Special responsibilities: Board Chair and Chair of the Investment Committee.

Professor Christina Mitchell MBBS, PhD

Professor Mitchell is the Dean of the Faculty of Medicine, Nursing and Health Sciences at Monash University. A physician-scientist specialising in clinical haematology, her previous positions with the University include Head of the Department of Biochemistry and Molecular Biology, which quadrupled its size and research budget under her leadership, and Head of the School of Biomedical Sciences.

A member of the NHMRC Research Fellowships Peer Review Panel and the scientific advisory panels of the Garvan Institute and Peter MacCallum Research Institute, Professor Mitchell has previously been a director of veski and member of the scientific advisory panels of Cancer Council Victoria and the FSHD Global Research Foundation. She is a Director on the Boards of Baker IDI Heart and Diabetes Institute, Burnet Institute and the Victorian Institute of Forensic Medicine Council.

Mr Graeme Wise BEco (Monash), FAICD

Mr Wise began his career as a marketing specialist, including 15 years at Alcoa, based in both Australia and the UK. In 1981, he moved to retailing with Myer before founding Adidem Pty Ltd to build and operate the Australian branch of the Body Shop chain of retail stores. Mr Wise is now Chairman of the Adidem Group, which comprises companies in publishing, hospitality and computer solution businesses. Mr Wise is also involved in philanthropic activities as a patron of the Big Issue newspaper and founder of the Wise Foundation.

Professor Pauline Nestor BA (Hons), MPhil, DPhil

Professor Nestor is Vice-Provost (Research) at Monash University. Previous appointments at Monash University have included Associate Dean (Research) in the Faculty of Arts, and Academic Adviser to the Office of the Deputy Vice-Chancellor (Research). A highly published expert in nineteenth-century English literature and culture, Professor Nestor completed a BA (Hons) at Melbourne University, before attending Oxford University as a Rhodes Scholar. She is also a Director on the Board of the Institute for Safety, Compensation and Recovery Research (ISCRR).

Ms Maria Trinci BA/BComm, CA

Ms Trinci has worked with KPMG, specialising in Financial Services since 2000, and was admitted to the partnership in 2012. Ms Trinci is currently the engagement partner for ANZ. She has worked in the banking industry in London, Edinburgh, Glasgow and New York with clients including Mellon, Deutsche Bank and Citigroup. Maria is also a volunteer board member and pro bono audit provider. She is Deputy Chair of the Cancer Council Victoria Board and chairs their Finance, Risk and Audit Committee (FRAC). She is involved in a variety of community service groups including the Ovarian Cancer Research Foundation (OCRF), Crime Stoppers, Gay and Lesbian Switchboard Victoria and the Committee For Melbourne – Future Focus Leadership Program.

Special responsibilities:
Chair, Finance and Audit Committee.

Professor Warwick Anderson AM BSc (Hons) UNE, PhD (Adelaide), D Univ (Adelaide), FAHA (Int), FRCPA (Hon)

Professor Anderson is the Secretary General of the Human Frontier Science Program, funding international cooperation in research into the complex mechanisms of living organisms. He was previously CEO of the National Health and Medical Research Council of Australia (NHMRC), and held research positions at Monash University, Baker Medical Research Institute, University of Sydney and Harvard Medical School.

Professor Anderson’s research focuses on the renal causes of hypertension, including humoural, neural and vascular remodelling aspects, resulting in 170 peer-reviewed articles. He was previously a member of numerous international bodies collaborating in medical research. He was made a Member of the Order of Australia in 2005.

Mr Nigel Garrard BEcomm, AICD, CA

Mr Garrard has been the Managing Director and CEO of Orora Limited since 2013 when it listed on the ASX.  Mr Garrard began his career at KPMG, and has since held a number of senior executive postings including as the Managing Director of SPC Ardmona; Coca Cola Amatil’s Food & Service division; Chiquita Brands South Pacific Ltd.; and Amcor Australasia and Packaging Distribution. He is the former Chairman of the Federal Government’s National Food Industry Strategy Ltd and has been a Director of a number of industry and not for profit organisations. Mr Garrard is a Director of the Packaging Council of Australia and Orora Ltd.

Mr Andrew Leyden BComm, AICD, CA

Mr Leyden has been the Managing Director of Lazard Corporate Advisory and its predecessors since 2002. He has also worked for Credit Suisse Group, ANZ McCaughan Dyson and Arthur Andersen. Andrew is a member of University of Melbourne Business Leadership Roundtable, Faculty of Business and Economics.

Ms Zita Peach BSc, AICD

Ms Peach has been the Principal of Zita Peach Business Development Services since 2015. She has also worked as Managing Director of Fresenius Kabi, Vice President of Business development at CSL, Commercial Director at Merck Sharp & Dohma and in a range of positions with Amrad Corporation. Ms Peach is a Member of the Australian Institute of Company Directors and a Fellow of the Australian Marketing Institute. She is a Director of Starpharma Holdings, Vision Eye Institute and 4DX Molecular Diagnostics

Professor Erwin Loh, MBBS, LLB (Hons), MHSM, MBA, PhD, FAIM, FCMI, FAICD, FACLM, FCHSM, FRACMA

Professor Erwin Loh is Chief Medical Officer and Executive Director of Innovation, Patient Safety and Experience at Monash Health, Victoria’s largest health service. Prior to this he was the Deputy Chief Medical Officer at the Peter MacCallum Cancer Centre. He is a Barrister and Solicitor of the Supreme Court of Victoria and High Court of Australia. He has a medical degree from the University of Melbourne, and a law degree with honours from Monash University. He also has an MBA, Master of Health Service Management, and PhD with his thesis examining doctors in senior hospital management. He is Fellow of the Royal Australasian College of Medical Administrators, Australasian College of Health Service Management, Australian Institute of Company Directors, and Australasian College of Legal Medicine.

Besides being a current Board Member of the Hudson Institute of Medical Research, he is also on the Board of the Monash Health Research Precinct and the Australasian College of Legal Medicine (where he is also Vice President). He has previously been on the Board of the Australian Medical Association (Victoria), the Law Institute of Victoria, and the Royal Australasian College of Medical Administrators. He is adjunct Clinical Professor at Monash University where he teaches health law and health services management. He is the Chair of the Victorian State Committee of the Royal Australasian College of Administrators. He has been an invited speaker of local and international conferences, published articles and book chapters on health law and medical management, and supervises doctoral students.

Company Secretary

Mr Rob Merriel

BA, Grad Dip (Psych), Grad Dip (Accounting), CPA

Mr Merriel is a Certified Practicing Accountant (CPA) with more than 30 years’ experience working in medical research (Baker IDI), healthcare (Melbourne Health and Southern Health) and commercial organisations (Pacific Dunlop and Deloitte Consulting). The current Chief Financial Officer of the Institute, Mr Merriel was previously the Director and Company Secretary of several biotechnology-focused companies, including BioGrid Australia, Biocomm, the Australian Technology Fund, and Evivar.

Board Committees

Finance and Audit Committee

The role of this committee is to assist the board in its oversight of the internal control and compliance, accounting and financial reporting, and risk management processes of the Institute.

Members: Ms Maria Trinci (Chair since March 2016), Ms Carmel Mortell and Secretary Mr Rob Merriel. Professor Williams attends by invitation.

Intellectual Property and Commercialisation Committee

The role of this committee is to advise the Board and Director on statutory requirements for corporate governance and commercialisation of the institute’s intellectual property and related issues.

Members: Mrs Zita Peach (Chair), Dr Andrew Gearing, Mr Grant Fisher, Dr Michael Pannacio, Mr Robert Klupacs and Secretary Mr Rob Merriel. Professor Williams attends by invitation.

Investment Committee

The role of this committee is to advise the Board and Director on the effectiveness of investment policies, approval of the engagement of investment managers and investment transactions.

Members: Mr Andrew Leyden (Chair), Mr Nigel Garrard, Ms Maria Trinci and Secretary Mr Rob Merriel.